0 和譽-B(02256):Pimicotinib (ABSK021)治療晚期胰腺癌II期臨牀試驗完成國內首例患者給藥 November 27, 2023 by · Published November 27, 2023
0 川環科技(300547.SZ)發預增,預計2023年度淨利潤約1.5億元至1.84億元,同比增長22.53%至50.3% January 29, 2024 by · Published January 29, 2024